VO₂ max is no longer just a benchmark for elite endurance—it’s a functional biomarker with direct implications for metabolic health, weight management, and sustainable training. But not all VO₂ max estimates are created equal. When the goal shifts from “What’s my aerobic ceiling?” to “How efficiently am I burning fat at moderate intensities?”, the algorithmic architecture behind the number becomes critical. The Garmin Forerunner 265 and Coros Pace 3 both report VO₂ max values prominently—but they derive them through fundamentally different physiological models, sensor fusion strategies, and calibration logic. One prioritizes longitudinal trend fidelity; the other emphasizes acute metabolic responsiveness. This distinction directly affects how reliably each watch infers fat oxidation efficiency—the rate at which your body preferentially taps into stored triglycerides during sub-threshold effort. In this analysis, we move beyond spec sheets and marketing claims to examine what the data reveals: where each device excels, where it falters, and how their VO₂ max outputs translate—biologically—to real-world fuel utilization.
Why VO₂ max estimation matters for fat oxidation efficiency
Fat oxidation efficiency isn’t measured directly by consumer wearables. Instead, it’s inferred from the relationship between oxygen consumption, heart rate, power (or pace), and respiratory exchange ratio (RER)—a value requiring lab-grade gas analyzers. Since wrist-based devices can’t measure RER, they rely on validated physiological models that link VO₂ max to the *intensity domain* where maximal fat oxidation (MFO) typically occurs—usually between 45–65% of VO₂ max. A precise VO₂ max estimate anchors this entire inference chain. Overestimate VO₂ max by 8%, and the watch may misplace your MFO zone 2–3 bpm lower than reality—potentially causing you to train too hard in “fat-burning” zones or miss metabolic adaptations entirely. Underestimate it, and you risk underevaluating your aerobic readiness and misinterpreting recovery capacity. As Dr. Stephen Seiler, exercise physiologist and co-author of Training Theory and Methodology, explains:
“VO₂ max estimation in field devices is only as useful as its consistency with the individual’s true ventilatory threshold behavior. If the algorithm doesn’t respect the non-linear relationship between HR and VO₂ near lactate turnpoint—or fails to account for day-to-day autonomic variability—it will generate a number that looks plausible but misleads metabolic zone assignment.” — Dr. Stephen Seiler, University of Agder, Norway
This is why comparing the Forerunner 265 and Pace 3 demands more than checking which displays a higher number. It requires dissecting how each calculates that number—and whether its calculation preserves the physiological gradients needed to predict when and how effectively your body switches from carb to fat fuel.
Core methodology: How each device estimates VO₂ max
The Forerunner 265 uses Garmin’s proprietary Firstbeat Analytics engine, now in its fourth generation. It relies on a multi-input regression model trained on over 10,000 lab-verified VO₂ max tests. Inputs include resting HRV (via nightly measurements), running dynamics (vertical oscillation, ground contact time), pace, elevation change, and heart rate response across multiple intensities. Crucially, it applies a *trend-weighted smoothing filter*: recent consistent efforts carry more influence than isolated outliers. This improves long-term tracking but dampens responsiveness to acute fitness shifts—such as those following a focused 3-week aerobic base block.
The Coros Pace 3 uses a hybrid approach combining Coros’ own metabolic modeling (developed with input from the Norwegian School of Sport Sciences) and elements of the ACSM metabolic equation. Its algorithm places heavier emphasis on *real-time cardiac drift* during steady-state runs—specifically how much HR rises per minute at a constant pace—as a proxy for thermoregulatory and fatigue-related oxygen cost. It also integrates altitude acclimatization status and sleep-recovery metrics (via HRV and movement patterns) but does not require overnight HRV measurement to generate an initial VO₂ max value. Unlike Garmin’s model, Coros updates its estimate after every qualifying run (>15 minutes, HR >70% max), making it more reactive—but potentially more volatile in response to dehydration or poor sleep.
Tip: For the most stable VO₂ max baseline on the Forerunner 265, complete three 20+ minute runs at conversational pace within 5 days—ideally under similar environmental conditions. Coros Pace 3 benefits more from one longer run (>35 min) at a steady, moderate intensity (e.g., 8:30–9:00/km for a 45-min 10K runner).Validation against gold-standard testing: What independent studies show
Two peer-reviewed field validations provide insight. A 2023 study published in Frontiers in Physiology tested 42 recreational runners (VO₂ max range: 41–62 mL/kg/min) using both devices alongside treadmill ramp tests and indirect calorimetry. Key findings:
- Garmin Forerunner 265 mean absolute error (MAE): 3.2 mL/kg/min — with strongest agreement in subjects with stable training habits (>3 months consistent volume). Error increased to 4.7 mL/kg/min in those returning from injury.
- Coros Pace 3 MAE: 2.9 mL/kg/min — slightly better overall accuracy, but with higher variance (±1.8 vs Garmin’s ±1.1). Notably, Pace 3 underestimated VO₂ max in 68% of subjects with high HRV coherence (indicating strong parasympathetic tone), suggesting its cardiac-drift model may overattribute low HR response to fitness rather than vagal dominance.
- Both devices showed systematic bias below 45 mL/kg/min: Garmin overestimated by ~2.1%; Coros underestimated by ~1.8%. This has direct implications for fat oxidation modeling, as MFO zone calculations become increasingly sensitive in lower-aerobic-capacity populations.
A second validation—conducted by the German Sports University Cologne in early 2024—added metabolic context. Researchers used the devices’ VO₂ max outputs to calculate predicted MFO zones (using the widely accepted “Fatmax” formula: MFO = 0.55 × VO₂ max), then compared predictions against actual fat oxidation rates measured via indirect calorimetry at 10 intensities. Results revealed a critical divergence:
| Device | Average MFO Prediction Error (kcal/min) | Zone Alignment Accuracy (% of time spent in predicted MFO zone matching actual MFO intensity) | Notable Bias |
|---|---|---|---|
| Garmin Forerunner 265 | 0.41 kcal/min | 73% | Tended to shift MFO zone ~2 bpm too high in heat/humidity due to overreliance on pace-derived inputs |
| Coros Pace 3 | 0.33 kcal/min | 81% | Underpredicted MFO zone in well-rested athletes—likely because cardiac drift was minimal, leading to inflated VO₂ max and thus elevated MFO threshold |
This confirms that while Coros delivers marginally tighter raw VO₂ max accuracy, Garmin’s model yields more metabolically conservative (and often safer) zone assignments for fat oxidation work—particularly in variable conditions.
Practical impact on training: Real-world case study
Sarah, 38, a recreational triathlete training for her first Ironman, used both watches over a 12-week base-building phase. Her lab-tested VO₂ max was 48.2 mL/kg/min. Initially, the Forerunner 265 reported 47.5; the Pace 3 reported 49.1. Both placed her MFO zone between 138–148 bpm. After week 6—following two weeks of high-volume Zone 2 cycling and daily HRV-guided recovery—the Forerunner 265 updated to 48.3 (a +0.8 change); the Pace 3 jumped to 50.6 (+1.5).
Sarah followed each watch’s “Fat Burn” zone recommendations for 3 weekly 90-minute runs. At week 8, she repeated a standardized 60-minute treadmill test at 145 bpm. Indirect calorimetry revealed her actual fat oxidation rate peaked at 142 bpm—not 145. The Forerunner 265’s conservative update kept her within 3 bpm of optimal; the Pace 3’s aggressive revision pushed her 3 bpm above peak fat burn, shifting substrate use toward ~12% more carbohydrate reliance per hour. Over 12 weeks, that translated to ~4,200 fewer calories from fat—equivalent to nearly 0.6 kg of body fat unutilized. Sarah switched to using the Forerunner 265’s VO₂ max for zone setting, while using the Pace 3’s real-time cardiac drift metric as a fatigue-alert tool instead.
Actionable optimization checklist
To maximize the metabolic utility of either device’s VO₂ max output—especially for fat oxidation goals—follow this evidence-based checklist:
- Validate baseline first: Get a lab VO₂ max test (or at minimum, a field test like the Cooper 12-minute run) before relying on wearable estimates.
- Control for confounders: Avoid VO₂ max–updating runs within 24 hours of alcohol, caffeine >200 mg, or sleep <6.5 hours—both algorithms are sensitive to autonomic disruption.
- Prefer steady-state over interval sessions: Runs with consistent pace and HR (e.g., 30–45 min at Zone 2) yield more reliable VO₂ max updates than interval workouts, which introduce noise from anaerobic contribution.
- Reassess seasonally: Update your VO₂ max baseline every 8–10 weeks—not after every run—to avoid algorithmic whiplash and preserve metabolic zone integrity.
- Triangulate with perceived exertion: If your “Fat Burn” zone feels consistently harder than “conversational,” your VO₂ max is likely overestimated. Dial back zone upper limits by 2–3 bpm and re-evaluate after two sessions.
FAQ: Addressing common misconceptions
Does a higher VO₂ max number always mean better fat oxidation efficiency?
No. Fat oxidation efficiency depends more on mitochondrial density, capillary supply, and enzyme activity (e.g., HADH, CPT1) than on VO₂ max alone. Two athletes with identical VO₂ max values may have MFO peaks differing by 15–20 bpm due to training history—endurance-trained individuals often shift MFO to higher intensities, while those new to aerobic work hit peak fat burn at lower percentages of VO₂ max. Neither watch accounts for this individual metabolic phenotype—so treat their MFO zones as starting points, not absolutes.
Can I improve my watch’s VO₂ max estimation accuracy with firmware updates?
Yes—but selectively. Garmin’s 18.00 firmware (released Q2 2024) improved VO₂ max stability for users with high HRV variability by introducing dynamic weighting of resting HRV inputs. Coros’ 7.0 firmware refined cardiac drift detection in humid conditions. However, neither update changes the core physiological assumptions. Firmware helps reliability, not fundamental model validity.
Do GPS inaccuracies affect VO₂ max estimation?
Indirectly, yes—especially for Garmin. Its model uses pace as a primary input; poor GPS signal (e.g., tree cover, urban canyons) creates erroneous pace spikes, which the algorithm interprets as inefficient oxygen use. Coros relies less on pace and more on HR kinetics, making it more robust in GPS-challenged environments—but more vulnerable to HR strap slippage or skin conductivity issues.
Conclusion: Choosing alignment over accuracy
The Garmin Forerunner 265 and Coros Pace 3 aren’t competing for who reports the “truest” VO₂ max—they’re optimized for different priorities. The Forerunner 265 prioritizes metabolic conservatism, trend fidelity, and integration with broader training load metrics (like Training Status and Recovery Time). Its VO₂ max serves best as a stable anchor for long-term zone planning—particularly if your goal is sustainable fat utilization across seasons. The Coros Pace 3 prioritizes acute physiological responsiveness and real-time cardiac feedback; its VO₂ max shines when you need rapid insight into short-term fatigue or adaptation, but demands more manual verification for metabolic zone precision.
Neither watch replaces lab testing—but both can significantly enhance your ability to train intelligently *between* tests. The key is understanding what each number represents biologically, not just numerically. Stop asking, “Which is more accurate?” Start asking, “Which model aligns better with how my body actually fuels itself—and how I intend to use that information?” That shift in framing transforms VO₂ max from a static score into a dynamic lever for metabolic health.
💬 Your experience matters. Have you tracked fat oxidation changes using either watch? Did VO₂ max updates match your perceived progress—or reveal unexpected plateaus? Share your insights in the comments to help others navigate the physiology behind the pixels.









